208 related articles for article (PubMed ID: 32157241)
1. An integrated analysis of lymphocytic reaction, tumour molecular characteristics and patient survival in colorectal cancer.
Haruki K; Kosumi K; Li P; Arima K; Väyrynen JP; Lau MC; Twombly TS; Hamada T; Glickman JN; Fujiyoshi K; Chen Y; Du C; Guo C; Väyrynen SA; Dias Costa A; Song M; Chan AT; Meyerhardt JA; Nishihara R; Fuchs CS; Liu L; Zhang X; Wu K; Giannakis M; Nowak JA; Ogino S
Br J Cancer; 2020 Apr; 122(9):1367-1377. PubMed ID: 32157241
[TBL] [Abstract][Full Text] [Related]
2. Analyses of clinicopathological, molecular, and prognostic associations of KRAS codon 61 and codon 146 mutations in colorectal cancer: cohort study and literature review.
Imamura Y; Lochhead P; Yamauchi M; Kuchiba A; Qian ZR; Liao X; Nishihara R; Jung S; Wu K; Nosho K; Wang YE; Peng S; Bass AJ; Haigis KM; Meyerhardt JA; Chan AT; Fuchs CS; Ogino S
Mol Cancer; 2014 May; 13():135. PubMed ID: 24885062
[TBL] [Abstract][Full Text] [Related]
3. TGFBR2 and BAX mononucleotide tract mutations, microsatellite instability, and prognosis in 1072 colorectal cancers.
Shima K; Morikawa T; Yamauchi M; Kuchiba A; Imamura Y; Liao X; Meyerhardt JA; Fuchs CS; Ogino S
PLoS One; 2011; 6(9):e25062. PubMed ID: 21949851
[TBL] [Abstract][Full Text] [Related]
4. CDK8 expression in 470 colorectal cancers in relation to beta-catenin activation, other molecular alterations and patient survival.
Firestein R; Shima K; Nosho K; Irahara N; Baba Y; Bojarski E; Giovannucci EL; Hahn WC; Fuchs CS; Ogino S
Int J Cancer; 2010 Jun; 126(12):2863-73. PubMed ID: 19790197
[TBL] [Abstract][Full Text] [Related]
5. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis.
Mima K; Nishihara R; Qian ZR; Cao Y; Sukawa Y; Nowak JA; Yang J; Dou R; Masugi Y; Song M; Kostic AD; Giannakis M; Bullman S; Milner DA; Baba H; Giovannucci EL; Garraway LA; Freeman GJ; Dranoff G; Garrett WS; Huttenhower C; Meyerson M; Meyerhardt JA; Chan AT; Fuchs CS; Ogino S
Gut; 2016 Dec; 65(12):1973-1980. PubMed ID: 26311717
[TBL] [Abstract][Full Text] [Related]
6. Specific mutations in KRAS codons 12 and 13, and patient prognosis in 1075 BRAF wild-type colorectal cancers.
Imamura Y; Morikawa T; Liao X; Lochhead P; Kuchiba A; Yamauchi M; Qian ZR; Nishihara R; Meyerhardt JA; Haigis KM; Fuchs CS; Ogino S
Clin Cancer Res; 2012 Sep; 18(17):4753-63. PubMed ID: 22753589
[TBL] [Abstract][Full Text] [Related]
7. Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial.
Tabernero J; Lenz HJ; Siena S; Sobrero A; Falcone A; Ychou M; Humblet Y; Bouché O; Mineur L; Barone C; Adenis A; Yoshino T; Goldberg RM; Sargent DJ; Wagner A; Laurent D; Teufel M; Jeffers M; Grothey A; Van Cutsem E
Lancet Oncol; 2015 Aug; 16(8):937-48. PubMed ID: 26184520
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D status after colorectal cancer diagnosis and patient survival according to immune response to tumour.
Hamada T; Liu L; Nowak JA; Mima K; Cao Y; Ng K; Twombly TS; Song M; Jung S; Dou R; Masugi Y; Kosumi K; Shi Y; da Silva A; Gu M; Li W; Keum N; Wu K; Nosho K; Inamura K; Meyerhardt JA; Nevo D; Wang M; Giannakis M; Chan AT; Giovannucci EL; Fuchs CS; Nishihara R; Zhang X; Ogino S
Eur J Cancer; 2018 Nov; 103():98-107. PubMed ID: 30219720
[TBL] [Abstract][Full Text] [Related]
9. Lymphocytic reaction to colorectal cancer is associated with longer survival, independent of lymph node count, microsatellite instability, and CpG island methylator phenotype.
Ogino S; Nosho K; Irahara N; Meyerhardt JA; Baba Y; Shima K; Glickman JN; Ferrone CR; Mino-Kenudson M; Tanaka N; Dranoff G; Giovannucci EL; Fuchs CS
Clin Cancer Res; 2009 Oct; 15(20):6412-20. PubMed ID: 19825961
[TBL] [Abstract][Full Text] [Related]
10. Prognostic role of PIK3CA mutation in colorectal cancer: cohort study and literature review.
Liao X; Morikawa T; Lochhead P; Imamura Y; Kuchiba A; Yamauchi M; Nosho K; Qian ZR; Nishihara R; Meyerhardt JA; Fuchs CS; Ogino S
Clin Cancer Res; 2012 Apr; 18(8):2257-68. PubMed ID: 22357840
[TBL] [Abstract][Full Text] [Related]
11. Tumor LINE-1 methylation level and colorectal cancer location in relation to patient survival.
Mima K; Nowak JA; Qian ZR; Cao Y; Song M; Masugi Y; Shi Y; da Silva A; Gu M; Li W; Hamada T; Zhang X; Wu K; Meyerhardt JA; Baba H; Giovannucci EL; Chan AT; Fuchs CS; Ogino S; Nishihara R
Oncotarget; 2016 Aug; 7(34):55098-55109. PubMed ID: 27391152
[TBL] [Abstract][Full Text] [Related]
12. Prognostic association of PTGS2 (COX-2) over-expression according to BRAF mutation status in colorectal cancer: Results from two prospective cohorts and CALGB 89803 (Alliance) trial.
Kosumi K; Hamada T; Zhang S; Liu L; da Silva A; Koh H; Twombly TS; Mima K; Morikawa T; Song M; Nowak JA; Nishihara R; Saltz LB; Niedzwiecki D; Ou FS; Zemla T; Mayer RJ; Baba H; Ng K; Giannakis M; Zhang X; Wu K; Giovannucci EL; Chan AT; Fuchs CS; Meyerhardt JA; Ogino S
Eur J Cancer; 2019 Apr; 111():82-93. PubMed ID: 30826660
[TBL] [Abstract][Full Text] [Related]
13. Associations between colorectal cancer molecular markers and pathways with clinicopathologic features in older women.
Samadder NJ; Vierkant RA; Tillmans LS; Wang AH; Weisenberger DJ; Laird PW; Lynch CF; Anderson KE; French AJ; Haile RW; Potter JD; Slager SL; Smyrk TC; Thibodeau SN; Cerhan JR; Limburg PJ
Gastroenterology; 2013 Aug; 145(2):348-56.e1-2. PubMed ID: 23665275
[TBL] [Abstract][Full Text] [Related]
14. Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review.
Nosho K; Baba Y; Tanaka N; Shima K; Hayashi M; Meyerhardt JA; Giovannucci E; Dranoff G; Fuchs CS; Ogino S
J Pathol; 2010 Dec; 222(4):350-66. PubMed ID: 20927778
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance and molecular associations of 18q loss of heterozygosity: a cohort study of microsatellite stable colorectal cancers.
Ogino S; Nosho K; Irahara N; Shima K; Baba Y; Kirkner GJ; Meyerhardt JA; Fuchs CS
J Clin Oncol; 2009 Sep; 27(27):4591-8. PubMed ID: 19704056
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes of patients with microsatellite-unstable colorectal carcinomas depend on L1 methylation level.
Rhee YY; Kim MJ; Bae JM; Koh JM; Cho NY; Juhnn YS; Kim D; Kang GH
Ann Surg Oncol; 2012 Oct; 19(11):3441-8. PubMed ID: 22618722
[TBL] [Abstract][Full Text] [Related]
17. Loss of CDH1 (E-cadherin) expression is associated with infiltrative tumour growth and lymph node metastasis.
Kim SA; Inamura K; Yamauchi M; Nishihara R; Mima K; Sukawa Y; Li T; Yasunari M; Morikawa T; Fitzgerald KC; Fuchs CS; Wu K; Chan AT; Zhang X; Ogino S; Qian ZR
Br J Cancer; 2016 Jan; 114(2):199-206. PubMed ID: 26742007
[TBL] [Abstract][Full Text] [Related]
18. Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum.
Yamauchi M; Morikawa T; Kuchiba A; Imamura Y; Qian ZR; Nishihara R; Liao X; Waldron L; Hoshida Y; Huttenhower C; Chan AT; Giovannucci E; Fuchs C; Ogino S
Gut; 2012 Jun; 61(6):847-54. PubMed ID: 22427238
[TBL] [Abstract][Full Text] [Related]
19. Prognostic implication of the CpG island methylator phenotype in colorectal cancers depends on tumour location.
Bae JM; Kim JH; Cho NY; Kim TY; Kang GH
Br J Cancer; 2013 Aug; 109(4):1004-12. PubMed ID: 23900220
[TBL] [Abstract][Full Text] [Related]
20. Unique clinicopathologic and genetic alteration features in early onset colorectal carcinoma compared with age-related colorectal carcinoma: a large cohort next generation sequence analysis.
Escobar D; Jones R; Gao J; Sun L; Liao J; Yang GY
Hum Pathol; 2020 Nov; 105():37-46. PubMed ID: 32916163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
